medigraphic.com
ISSN 1727-897X (Electronic)

2020, Number 5

<< Back Next >>

Medisur 2020; 18 (5)

Use of propranolol in facial segmental hemangioma. Regarding a case

Quintero DZ, González VN, González LSL, Sánchez GLA

Language: Spanish
References: 12
Page: 919-923
PDF size: 137.06 Kb.


ABSTRACT

Complications are frequent in childhood segmental hemangiomas, so treatment of these lesions is necessary.Propranolol is currently the first line treatment in these cases. The case of a one-month-old infant with a segmental hemangioma of the face, diagnosed and treated at the Pediatric Hospital of Cienfuegos, is reported. He was given propranolol and showed almost complete lesion regression, maintaining the treatment for one year and any complication occurred.


REFERENCES

  1. de la Cruz Y. Hemangioma infantil. Rev Cubana Angiol Cir Vasc [revista en Internet]. 2015 [citado 13 Mar 2019];16(1):[aprox. 16p]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1682-00372015000100010.

  2. Quintero Z, Atienza L, Sánchez L. Uso del propranolol en hemangioma parotídeo. Correo Científico Médico [revista en Internet]. 2015 [citado 10 Mar 2019];19(3):[aprox. 7p]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S156043812015000300021&lng=es&nrm=iso&tlng=es.

  3. Ata? E, Koç O, Art?k H. Clinical features and treatment results in children with hemangioma. The Turkish Journal of Pediatrics [revista en Internet]. 2017 [citado 17 Mar 2019]; :[aprox. 7p]. Disponible en: http://www.turkishjournalpediatrics.org/uploads/pdf_TJP_1713.pdf-E260.

  4. Bota M, Popa G, Blag CL, Leucuta DC, T?taru A. Infantile hemangiomas: a 7-year experience of a single-center. Clujul Med [revista en Internet]. 2017 [citado 17 Mar 2019];90(4):[aprox. 6p]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683828/.

  5. Baselga E, Bernabéu J, van Esso D, Febrer MI, Carrasco A, de Lucas R y colaboradores. Spanish consen us on infantile haemangioma. Anales de Pediatría [revista en Internet]. 2016 [citado 26 May 2018];85(5):[aprox. 10p]. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S2341287915002240.

  6. Fajire X, Navarrete J, Buchroithner H. Síndrome de PHACES. Rev. Chilena Dermatol [revista en Internet]. 2015 [citado 13 May 2018];31(2):[aprox. 9p]. Disponible en: http://www.sochiderm.org/web/revista/31_2/21.pdf.

  7. Smith CJF, Friedlander SF, Guma M, Kavanaugh A, Chambers CD. Infantile hemangiomas: an updated review on risk factors, pathogenesis, and treatment. Birth Defects Res [revista en Internet]. 2017 [citado 13 May 2018];109(11):[aprox. 6p]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839165/.

  8. Grzesik P, Wu JK. Current perspectives on the optimal management of infantile hemangioma. Pediatric Health Med Ther [revista en Internet]. 2017 [citado 13 May 2018];6(8):[aprox. 9p]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774589/.

  9. Bin Yang, Li Li, Li-xin Zhang, Yu-juan Sun, Lin Ma. Clinical Characteristics and Treatment Options of Infantile Vascular Anomalies. Medicine (Baltimore) [revista en Internet]. 2015 [citado 13 May 2018];94(40):[aprox. 26p]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616746/.

  10. Money S. The risks of chronic corticosteroid exposure. J Pain Palliat Care Pharmacother [revista en Internet]. 2017 [citado 13 May 2018];31(2):[aprox. 1p]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28375794/.

  11. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N England J Med [revista en Internet]. 2008 [citado 13 May 2018];358(24):[aprox. 3p]. Disponible en: https://www.nejm.org/.

  12. Léaute-Labrèze C, Boccara O, Degrugillier-Chopinet C, Mazereeuw-Hautier J, Prey S, Lebbé G, et al. Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review. Pediatrics [revista en Internet]. 2016 [citado 13 May 2018];138(4):[aprox. 16p]. Disponible en: https://www.nejm.org//content/138/4/e20160353.




2020     |     www.medigraphic.com